InvestorsHub Logo
Followers 89
Posts 17470
Boards Moderated 0
Alias Born 09/06/2006

Re: Whitewater55 post# 275885

Tuesday, 04/07/2020 8:16:45 AM

Tuesday, April 07, 2020 8:16:45 AM

Post# of 704692
This is a pending approval for Keytruda for all solid tumors with high mutational burden [(TMB-H) ≥10 mutations/megabase] and no approved treatment.

This is based on a trial that launched Dec 2015. That would be after the partial hold was imposed on DCVax-L. Point being, trials can be run, data obtained, BLA filed in a rational amount of time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News